The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Pharmaceutical Combinations - EP3463345

The patent EP3463345 was granted to Array Biopharma on Nov 2, 2022. The application was originally filed on Jun 2, 2017 under application number EP17807555A. The patent is currently recorded with a legal status of "Revoked".

EP3463345

ARRAY BIOPHARMA
Application Number
EP17807555A
Filing Date
Jun 2, 2017
Status
Revoked
Mar 22, 2024
Publication Date
Nov 2, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBAug 1, 2023KRAUS & LEDERER PARTGMBBADMISSIBLE
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBAug 1, 2023TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6217866
DESCRIPTIONUS8501758
DESCRIPTIONWO03077914
DESCRIPTIONWO2011025927
DESCRIPTIONWO2013078264
DESCRIPTIONWO2014063024
DESCRIPTIONWO9640210
INTERNATIONAL-SEARCH-REPORTUS2014222443
INTERNATIONAL-SEARCH-REPORTUS2014275136
INTERNATIONAL-SEARCH-REPORTUS2015164897
INTERNATIONAL-SEARCH-REPORTUS2015265616
INTERNATIONAL-SEARCH-REPORTUS2015273057
OPPOSITIONWO2011025927
OPPOSITIONWO2014063024
OPPOSITIONWO2017210538
SEARCHWO2012170715
SEARCHWO2015087279

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents